Whitney Ijem
Stock Analyst at Canaccord Genuity
(4.43)
# 323
Out of 5,134 analysts
115
Total ratings
49.02%
Success rate
23.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $415 → $429 | $329.49 | +30.20% | 10 | Feb 17, 2026 | |
| WVE Wave Life Sciences | Maintains: Buy | $40 → $43 | $12.76 | +236.99% | 3 | Feb 3, 2026 | |
| BMRN BioMarin Pharmaceutical | Upgrades: Buy | $84 → $98 | $59.70 | +64.15% | 9 | Jan 20, 2026 | |
| TNYA Tenaya Therapeutics | Maintains: Buy | $6 → $5 | $0.62 | +706.97% | 7 | Dec 18, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $148 → $204 | $80.22 | +154.30% | 8 | Dec 16, 2025 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $114 → $141 | $100.13 | +40.82% | 10 | Dec 12, 2025 | |
| GUTS Fractyl Health | Maintains: Buy | $6 → $8 | $0.40 | +1,909.55% | 2 | Nov 21, 2025 | |
| PASG Passage Bio | Maintains: Buy | $260 → $67 | $8.62 | +677.71% | 7 | Aug 14, 2025 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $11 → $14 | $4.52 | +209.73% | 11 | Aug 13, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $136 → $128 | $20.25 | +532.25% | 9 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $424 → $411 | $484.22 | -15.12% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.30 | +203.49% | 9 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $54 | $11.95 | +351.88% | 6 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $66 | $7.33 | +800.88% | 6 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $148 → $150 | $17.64 | +750.34% | 3 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $153.80 | - | 2 | Jan 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $120 → $240 | $9.16 | +2,520.09% | 4 | Jul 23, 2019 |
Alnylam Pharmaceuticals
Feb 17, 2026
Maintains: Buy
Price Target: $415 → $429
Current: $329.49
Upside: +30.20%
Wave Life Sciences
Feb 3, 2026
Maintains: Buy
Price Target: $40 → $43
Current: $12.76
Upside: +236.99%
BioMarin Pharmaceutical
Jan 20, 2026
Upgrades: Buy
Price Target: $84 → $98
Current: $59.70
Upside: +64.15%
Tenaya Therapeutics
Dec 18, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $0.62
Upside: +706.97%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $148 → $204
Current: $80.22
Upside: +154.30%
Rhythm Pharmaceuticals
Dec 12, 2025
Maintains: Buy
Price Target: $114 → $141
Current: $100.13
Upside: +40.82%
Fractyl Health
Nov 21, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $0.40
Upside: +1,909.55%
Passage Bio
Aug 14, 2025
Maintains: Buy
Price Target: $260 → $67
Current: $8.62
Upside: +677.71%
Taysha Gene Therapies
Aug 13, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $4.52
Upside: +209.73%
Ultragenyx Pharmaceutical
Aug 8, 2025
Maintains: Buy
Price Target: $136 → $128
Current: $20.25
Upside: +532.25%
Aug 6, 2025
Maintains: Hold
Price Target: $424 → $411
Current: $484.22
Upside: -15.12%
Jul 25, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.30
Upside: +203.49%
Jun 3, 2025
Maintains: Buy
Price Target: $74 → $54
Current: $11.95
Upside: +351.88%
May 13, 2025
Maintains: Buy
Price Target: $68 → $66
Current: $7.33
Upside: +800.88%
Nov 7, 2024
Maintains: Buy
Price Target: $148 → $150
Current: $17.64
Upside: +750.34%
Jan 21, 2020
Downgrades: Neutral
Price Target: n/a
Current: $153.80
Upside: -
Jul 23, 2019
Upgrades: Overweight
Price Target: $120 → $240
Current: $9.16
Upside: +2,520.09%